109 A novel Werner Syndrome mutation: Pharmacological treatment by read-through of nonsense mutations and epigenetic therapies

A. Ruben; R E Achenbach; Miguel Arocena-Sutz; Fabián Aldunate; Manel Esteller; Fernando Setién

doi:10.1016/s0959-8049(16)30007-7

Related publications

Article2015

A novel Werner Syndrome mutation: pharmacological treatment by read-through of nonsense mutations and epigenetic therapies

Rubén Agrelo, Miguel Arocena Sutz, Fernando Setién, Fabián Aldunate, Manel Esteller, Valeria da Costa, R E Achenbach

Article2005

Novel Mutation in the Per-Arnt-Sim Domain of KCNH2 Causes a Malignant Form of Long-QT Syndrome

Tom Rossenbacker, Kanigula Mubagwa, Roselie Jongbloed, Johan Vereecke, Koenraad Devriendt, Marc Gewillig, Edward Carmeliet, Désiré Collen, Hein Heidbüchel, Peter Carmeliet

Article2002

Female Pseudohermaphroditism Caused by a Novel Homozygous Missense Mutation of the GR Gene

Berenice B. Mendonça, Maristela V. Leite, Margaret de Castro, Tomoshige Kino, Lucila Leico Kagohara Elias, Tânia A.S.S. Bachega, Ivo J.P. Arnhold, George Chrousos, Ana Claudia Latrônico

Article2015

A novel FOXL2 gene mutation and BMP15 variants in a woman with primary ovarian insufficiency and blepharophimosis–ptosis–epicanthus inversus syndrome

Nikolaos Settas, Margarita Anapliotou, Emmanuel Kanavakis, Helen Fryssira, Christalena Sofocleous, Catherine Dacou‐Voutetakis, George Chrousos, Antonis Voutetakis

Article2025

Abstract A002: Epigenetic aging as a predictive biomarker of genetic and pharmacological vulnerabilities in cancer cells

Irene Fernández-Rebollo, Alyssa DiGilio, Athanasios Oikonomou, Lucia Trastulla, Manel Esteller, Francesco Iorio